Skip to main content
. 2016 Feb 24;156:171–182. doi: 10.1007/s10549-016-3726-y

Table 2.

Discrepancies in breast cancer risk estimation between iPrevent® and the chosen risk estimation model

Model selected iPrevent® risk estimates (%) IBIS or BOADICEA model risk estimates (%) Difference between iPrevent® and model used (%)
10-year Residual lifetime 10-year Residual lifetime 10-year Residual lifetime
IBIS 3.1 14.3 2.8 13.2 0.3 1.1
IBIS 4.7 8.2 3.9 6.8 0.8 1.4
IBIS 4.2 14.3 2.9 10.3 1.3 4
IBIS 2.7 9.5 2.3 8.1 0.4 1.4

Discrepancies were seen in 4 of 127 cases tested